Form 4: LENSAR Director Elizabeth O'Farrell Receives RSU Grant

Director Elizabeth G. O'Farrell was granted 17,421 restricted stock units as part of LENSAR, Inc.'s annual director compensation program.

Summary

• Director Elizabeth G. O'Farrell acquired 17,421 restricted stock units (RSUs) on June 3, 2026.
• The grant was issued as part of the company's standard non-employee director compensation program.
• Following this transaction, the director's total beneficial ownership of common stock increased to 67,368 shares.
• The RSUs represent a contingent right to receive one share of common stock per unit.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a routine administrative filing regarding director compensation with no material impact on the company's financial outlook.

Positives

• The grant aligns director compensation with shareholder interests through equity-based incentives.
• The transaction reflects standard corporate governance practices for non-employee director remuneration.

Negatives

• The issuance of RSUs results in potential future dilution for existing shareholders upon vesting.

Risks

• Vesting is contingent upon the director's continued service to the issuer through June 3, 2027.
• The value of the equity is subject to market volatility and the future performance of LENSAR, Inc. common stock.

Future Outlook

The RSUs are scheduled to vest in full on June 3, 2027, provided the director remains in service to the company.

Management Comments

• The RSUs were granted in accordance with the Issuer's non-employee director compensation program as a component of the Reporting Person's annual compensation.

Industry Context

StockSavvy.ai notes that equity-based compensation for board members is a standard industry practice in the medical device sector to ensure long-term alignment between leadership and shareholders.

Comparison to Industry Standards

• The use of RSU grants for non-employee directors is consistent with compensation structures at peer medical technology companies.
• The vesting period of one year is standard for annual director equity awards.

Corporate Governance

Stakeholder Impact

• Shareholders may experience minor dilution upon the eventual settlement of the RSUs.

Next Steps

• Vesting of the 17,421 RSUs on June 3, 2027.

Key Dates

Keywords

LENSAR, LNSR, Form 4, Director Compensation, Restricted Stock Units, Insider Ownership